Abstract
Image-guided locoregional therapies play a crucial role in the management of patients with hepatocellular carcinoma (HCC). Transarterial therapies consist of a group of catheter-based treatments where embolic agents are delivered directly into the tumor via their supplying arteries. Some of the transarterial therapies available include bland embolization (TAE), transarterial chemoembolization (TACE), drug-eluting beads–transarterial chemoembolization (DEB–TACE), selective internal radioembolization therapy (SIRT), and hepatic artery infusion (HAI). This article provides a review of pre-procedural, intra-procedural, and post-procedural aspects of each therapy, along with a review of the literature. Newer embolotherapy options and future directions are also briefly discussed.
Reference246 articles.
1. Definition of Hepatic Tumor Microcirculation by Single Photon Emission Computerized Tomography (SPECT);Gyves;J. Nucl. Med.,1984
2. Studies on the Blood Supply of Tumors in Man. III. Vascular Patterns of the Liver by Hepatic Arteriography in Vivo;Bierman;J. Natl. Cancer Inst.,1951
3. Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand?
4. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
5. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献